Новый раунд: $31M
“Early-stage pharma company creating first-in-class therapies boosting expression of therapeutic genes in diseased cells using saRNA.”
Новый раунд: $30M
“Autonomously running customer interactions.”
Новый раунд: $26.97M
“We provide competitive and flexible finance solutions to our specialist industry sectors, including industry, professions and renewables.”